Citation
82 FR 133
Multiple canonical documents share this first-page citation.
- National Cancer Institute; Amended Notice of Meeting Tuesday, January 3, 2017 82 FR 133
- National Cancer Institute; Amended Notice of Meeting Tuesday, January 3, 2017 82 FR 133
- National Heart, Lung, and Blood Institute; Notice of Closed Meeting Tuesday, January 3, 2017 82 FR 133
- National Heart, Lung, and Blood Institute; Notice of Closed Meeting Tuesday, January 3, 2017 82 FR 133
- Prospective Grant of Exclusive License: Development, Manufacture and Commercialization of Gene Therapy Products for Human Gene Therapy Use To Treat and/or Prevent Methylmalonic Acidemia (MMA) Tuesday, January 3, 2017 82 FR 132
- Prospective Grant of Exclusive License: Development, Manufacture and Commercialization of Gene Therapy Products for Human Gene Therapy Use To Treat and/or Prevent Methylmalonic Acidemia (MMA) Tuesday, January 3, 2017 82 FR 132
- Federal Register Vol. 82, No.1, January 3, 2017 Tuesday, January 3, 2017 82 FR 133